[Negative responses to metopirone in Cushing's syndrome due to adrenal cortex adenoma or adenomatosis].
D015065:17-Hydroxycorticosteroids / Q000652:urine; D015068:17-Ketosteroids / Q000652:urine; D000230:Adenocarcinoma / Q000150:complications; D000236:Adenoma / Q000150:complications; D000293:Adolescent; D000310:Adrenal Gland Neoplasms / Q000150:complications*; D000324:Adrenocorticotropic Hormone; D000328:Adult; D003480:Cushing Syndrome / Q000175:diagnosis* / Q000209:etiology; D003937:Diagnosis, Differential; D005260:Female; D006801:Humans; D007223:Infant; D008297:Male; D008797:Metyrapone; D008875:Middle Aged
D015065:17-Hydroxycorticosteroids; D015068:17-Ketosteroids; D000324:Adrenocorticotropic Hormone; D008797:Metyrapone
Rèponses nègatives ă la mètopirone dans le syndrome de Cushing par adènome ou adĕnomatose cortico-surrĕnale.